Literature DB >> 7985018

Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY.

C M Haqq1, C Y King, E Ukiyama, S Falsafi, T N Haqq, P K Donahoe, M A Weiss.   

Abstract

The pathway of male sexual development in mammals is initiated by SRY, a gene on the short arm of the Y chromosome. Its expression in the differentiating gonadal ridge directs testicular morphogenesis, characterized by elaboration of Müllerian inhibiting substance (MIS) and testosterone. SRY and MIS each belong to conserved gene families that function in the control of growth and differentiation. Structural and biochemical studies of the DNA binding domain of SRY (the HMG box) revealed a protein-DNA interaction consisting of partial side chain intercalation into a widened minor groove. Functional studies of SRY in a cell line from embryonic gonadal ridge demonstrated activation of a gene-regulatory pathway leading to expression of MIS. SRY molecules containing mutations associated with human sex reversal have altered structural interactions with DNA and failed to induce transcription of MIS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7985018     DOI: 10.1126/science.7985018

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  39 in total

Review 1.  Diagnosis and management of ambiguous genitalia.

Authors:  L D Sherman
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding.

Authors:  F H Allain; Y M Yen; J E Masse; P Schultze; T Dieckmann; R C Johnson; J Feigon
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  The role of intercalating residues in chromosomal high-mobility-group protein DNA binding, bending and specificity.

Authors:  Janet Klass; Frank V Murphy; Susan Fouts; Melissa Serenil; Anita Changela; Jessica Siple; Mair E A Churchill
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

4.  Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart.

Authors:  Andy Tseng; Joan Stabila; Beth McGonnigal; Naohiro Yano; Mao-Jing Yang; Yi-Tang Tseng; Pamela A Davol; Lawrence G Lum; James F Padbury; Ting C Zhao
Journal:  Cardiovasc Res       Date:  2010-04-21       Impact factor: 10.787

5.  Mouse model reveals the role of SOX7 in the development of congenital diaphragmatic hernia associated with recurrent deletions of 8p23.1.

Authors:  Margaret J Wat; Tyler F Beck; Andrés Hernández-García; Zhiyin Yu; Danielle Veenma; Monica Garcia; Ashley M Holder; Jeanette J Wat; Yuqing Chen; Carrie A Mohila; Kevin P Lally; Mary Dickinson; Dick Tibboel; Annelies de Klein; Brendan Lee; Daryl A Scott
Journal:  Hum Mol Genet       Date:  2012-06-20       Impact factor: 6.150

6.  Partial disomy of Xp and the presence of SRY in a phenotypic female.

Authors:  S Bajalica; E Blennow; A Tşezou; A Galla-Voumvouraki; M Alevizaki; C Sinaniotis; S Kitsiou-Tzeli
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

7.  Design of artificial sequence-specific DNA bending ligands.

Authors:  D A Liberles; P B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 8.  Molecular determinants of sexual differentiation.

Authors:  J S Wiener; M Marcelli; D J Lamb
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

9.  Human Sex Determination at the Edge of Ambiguity: INHERITED XY SEX REVERSAL DUE TO ENHANCED UBIQUITINATION AND PROTEASOMAL DEGRADATION OF A MASTER TRANSCRIPTION FACTOR.

Authors:  Joseph D Racca; Yen-Shan Chen; Yanwu Yang; Nelson B Phillips; Michael A Weiss
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

Review 10.  SOX genes: architects of development.

Authors:  H M Prior; M A Walter
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.